In a strategic maneuver aimed at streamlining its product portfolio, pharmaceuti...
One year after allying with the shared objective of enhancing health management ...
Recently, AbbVie disclosed positive outcomes from a second phase 3 trial of Boto...
After months of looking into various other possibilities, Fresh Tracks Therapeut...
In May of this year, the FDA issued a full response letter that delayed the laun...
After an unprecedented live return of mice from the International Space Station ...
AbCellera and Regeneron have extended their current multi-target collaboration t...
The European Commission granted approval for The Menarini Group’s Orserdu to tre...
Benelux offers much potential for companies distributing innovative medicines, b...
Fresh Tracks is planning to seek approval for liquidation and dissolution from s...
The US FDA has accepted Takeda’s NDA resubmission for TAK-721 for the short-term...
Kezar and Everest Medicines have signed a deal for the development and commercia...
On 15 September 2023, the US Food and Drug Administration (FDA) approved GlaxoSm...
The collaboration will use Evaxion’s EDEN platform to bring an AI-designed gonor...
Regulatory applications in EU and the UK will follow a potential filing in the U...
The licence grants Meitheal marketing rights for insulin aspart, lispro, and gla...
